These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5007105)

  • 1. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitors.
    Hoffmann KJ; Stenberg P; Ljunggren C; Svensson U; Nilsson JL
    J Med Chem; 1975 Mar; 18(3):278-84. PubMed ID: 1133818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diamines.
    Ljunggren C; Hoffmann KJ; Stenberg P; Svensson U; Nilsson JL; Hartkoorn A; Lundén R
    J Med Chem; 1974 Jun; 17(6):649-51. PubMed ID: 4829944
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin-stabilizing factor inhibitors. 3. Sulphonamides related to monodansylcadaverine.
    Nilsson JL; Stenberg P; Ljunggren C; Eriksson O; Lundén R
    Acta Pharm Suec; 1971 Nov; 8(5):497-504. PubMed ID: 5159519
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Substituted imidazo[1,2-d][1,2,4]-thiadiazoles: a novel class of factor XIIIa inhibitors.
    Leung-Toung R; Tam TF; Wodzinska JM; Zhao Y; Lowrie J; Simpson CD; Karimian K; Spino M
    J Med Chem; 2005 Apr; 48(7):2266-9. PubMed ID: 15801818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin and coagulation factor XIII increases blood platelet adhesion to fibrin.
    Hansen MS
    Thromb Res; 1984 Jun; 34(6):551-6. PubMed ID: 6740571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of platelet aggregation. 3. ((Dialkylamino)alkyl)thio heterocyclic compounds.
    Wheelock RH; Elslager EF; Haley NF; McLean JR; Potoczak D; Veloso H
    J Med Chem; 1972 Jan; 15(1):61-5. PubMed ID: 5007095
    [No Abstract]   [Full Text] [Related]  

  • 8. [The role of cathepsin D in inactivation of platelet factor 4 and the platelet fibrin stabilizing factor].
    Ostrowska H; Worowski K
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1984-1985; 29-30():145-52. PubMed ID: 6443813
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombotic action of nicotinic acid].
    Baluda VP; Eristavi ZA; Sushkevich GN
    Kardiologiia; 1974 Nov; 14(11):105-7. PubMed ID: 4139303
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants.
    Wood S
    J Med; 1974; 5(1):7-22. PubMed ID: 4134042
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrin-stabilizing factor inhibitors.
    Nilsson JL; Stenberg P; Ljunggren C; Hoffman KJ; Lundén R; Eriksson O; Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():286-96. PubMed ID: 4508928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of platelet function (mode of action of platelet inhibitors) (author's transl)].
    Baumgartner HR
    Ther Umsch; 1977 May; 34(5):341-6. PubMed ID: 867315
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():6-30. PubMed ID: 4565370
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure-dependent inhibition by synthetic fibrinolytic anions of collagen-induced aggregation of human platelets.
    Thilo D; Von Kaulla KN
    J Med Chem; 1970 May; 13(3):503-10. PubMed ID: 5441134
    [No Abstract]   [Full Text] [Related]  

  • 17. Thiolester substrates for transamidating enzymes: studies on fibrinoligase.
    Lorand L; Chou CH; Simpson I
    Proc Natl Acad Sci U S A; 1972 Sep; 69(9):2645-8. PubMed ID: 4506787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of indomethacin, dissolved in dehydrocholic acid, on fibrolysis, fibrin solidification phase and thrombocyte aggregation].
    Holzhüter H; Wenzel E; Angelkort B
    Verh Dtsch Ges Inn Med; 1974; 80():1439-42. PubMed ID: 4454449
    [No Abstract]   [Full Text] [Related]  

  • 19. alpha-Halogenmethyl carbonyl compounds as very potent inhibitors of factor XIIIa in vitro.
    Reinhardt G
    Ann N Y Acad Sci; 1981; 370():836-42. PubMed ID: 6115611
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitors of platelet aggregation. 1. 5,10-Dihydro-3-(phenyl, thienyl, and furyl)thiazolo(3,2-b)(2,4)benzodiazepines and related compounds.
    Elslager EF; McLean JR; Perricone SC; Potoczak D; Veloso H; Worth DF; Wheelock RH
    J Med Chem; 1971 May; 14(5):397-401. PubMed ID: 5117685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.